Press Release
Consult the important information that Servier Canada wishes to share with the press in the form of press releases.
2024, February 20
FDA and EMA Accept Vorasidenib Regulatory Submissions for Marketing Approval of Vorasidenib for the Treatment of IDH-mutant Diffuse Glioma
2023, June 5